Warfarin in atrial fibrillation patients with moderate chronic kidney disease

Cited by (204)

Items 201–204 of 204

1. How to Safely Anticoagulate Patients With Renal Impairment
   Nadir Zulfiqar Aziz, Robyn Haysom, Jecko V. Thachil, Dawn Swan · 2026 · British Journal of Hospital Medicine
2. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
   Emelia J. Benjamin, Gregory M. Marcus, Paul L. Hess, Daniel Addison, Joseph G. Akar, Nicholas Keisuke Brownell, Janice Y. Chyou, Catherine G. Derington, Rebecca L. Diekemper, David S. Frankel et al. · 2026 · Journal of the American College of Cardiology
3. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
   Emelia J. Benjamin, Gregory M. Marcus, Paul L. Hess, Daniel Addison, Joseph G. Akar, Nicholas Keisuke Brownell, Janice Y. Chyou, Catherine G. Derington, Rebecca L. Diekemper, David S. Frankel et al. · 2026 · Circulation Population Health and Outcomes
4. Direct Oral Anticoagulants in the Cardiorenal Patient: Pharmacology, Kidney Function Estimation and Dose Selection Across the CKD Spectrum
   Alessandra Sorce, Maria Elena Ciuppa, Roberta Germanà, Giancarlo Altieri, Claudio Zinno, Carmelo Zumbino, Giuseppe Puccia, Salvatore Evola, Giuseppe Mulè, Caterina Carollo · 2026 · Current Issues in Molecular Biology